28
Participants
Start Date
August 5, 2024
Primary Completion Date
June 6, 2025
Study Completion Date
August 9, 2026
Biofeedback
To facilitate PFM function, electromyography biofeedback and electrical stimulation will be employed using an intravaginal probe, tailored to individual needs.
HIFEM
The HIFEM device (i.e. BTL EMSELLA) is FDA approved and its indications are to provide entirely non-invasive electromagnetic stimulation of pelvic floor muscle for the purpose of rehabilitation of weak pelvic muscles and restoration of neuromuscular control for the treatment of male and female urinary incontinence.
RECRUITING
National Taiwan University Hospital, Taipei
National Taiwan University Hospital
OTHER